- Jim Cramer's new stock picks focus on companies hit by recent market rotation rather than momentum stocks at record highs.
- Walmart, PepsiCo, Starbucks, TJX Companies and Johnson & Johnson are among the names Cramer believes now offer attractive entry points.
- Cramer also sees renewed upside in biotech and expects AI leadership to gradually rotate back toward large-cap technology companies.
Market rotation has rattled investors over the past week, but CNBC’s Jim Cramer believes the latest pullback is creating buying opportunities rather than signaling the start of a broader market downturn.
Instead of chasing high-flying semiconductor stocks that dominated the first half of 2026, Cramer says investors should focus on quality companies that have been caught in institutional selling despite little change to their long-term fundamentals.
His latest list of preferred stocks spans defensive retail, consumer staples, healthcare, biotech and select technology companies as investors reposition portfolios ahead of earnings season.
Walmart Tops Jim Cramer’s New Stock Picks
Among Jim Cramer’s new stock picks, Walmart received one of his strongest endorsements.
The retail giant has fallen roughly 18% from its May highs despite remaining one of the strongest defensive businesses in the market.
Cramer argues that lower fuel prices could reduce transportation costs while also leaving consumers with more disposable income. Combined with Walmart’s value-focused business model, those factors could help the retailer outperform if consumer spending weakens further.
He believes the recent decline reflects broader portfolio rotation rather than company-specific weakness, making Walmart an attractive buy-the-dip opportunity.
PepsiCo and Starbucks Could Benefit From the Rotation
Cramer also highlighted several consumer names that have recently lost momentum.
PepsiCo is approaching another earnings report after surrendering much of its recent rally, creating what Cramer views as a better risk-reward setup for long-term investors.
Starbucks also made his buy list as investors continue evaluating CEO Brian Niccol’s turnaround strategy.
The coffee chain remains under pressure following weaker consumer spending trends, but Cramer believes the recent pullback gives investors a more attractive entry point before operational improvements become more visible.
TJX Could Benefit From Consumer Weakness
Unlike traditional retailers, TJX Companies often performs well during periods of economic uncertainty.
As consumers become more price-conscious, discount retailers typically attract additional traffic while benefiting from excess inventory available from full-price competitors.
Cramer believes those conditions continue to favor TJX, making it one of the stronger retail names during the current market rotation.
Johnson & Johnson Offers Defensive Exposure
Healthcare remains another area where Cramer sees opportunity.
He pointed to Johnson & Johnson as a company that has become increasingly focused following the separation of its consumer health business.
The pharmaceutical and medical technology company continues to generate stable cash flow while offering investors defensive characteristics ahead of second-quarter earnings.
With healthcare lagging technology for much of this year, Cramer believes recent weakness has created a more attractive valuation.
AI Leadership May Be Changing
While artificial intelligence remains a dominant investment theme, Cramer believes leadership inside the sector is beginning to shift.
Rather than focusing solely on semiconductor manufacturers and AI hardware suppliers, investors are increasingly rotating toward the technology giants funding AI infrastructure and monetizing artificial intelligence applications.
Companies such as Microsoft, Alphabet, Amazon, Meta Platforms, Apple, Salesforce, Adobe and ServiceNow may benefit as investors look beyond chip manufacturers toward software platforms and cloud providers capable of generating recurring AI-related revenue.
Market Rotation Is Creating New Opportunities
Cramer views the recent weakness as a healthy rotation rather than the beginning of a prolonged correction.
Profit-taking in high-growth AI stocks has pushed capital into defensive sectors, healthcare, consumer companies and select technology names that had previously underperformed.
For long-term investors, he believes this environment offers better buying opportunities than simply chasing stocks already trading near record highs.
Outlook
Jim Cramer’s new stock picks reflect a strategy centered on quality rather than momentum.
Instead of adding exposure to the market’s biggest winners, he is focusing on companies with solid fundamentals that have been temporarily pressured by portfolio rotation.
With earnings season approaching, investors will be watching whether Walmart, PepsiCo, Starbucks, TJX, Johnson & Johnson and several biotech names can validate Cramer’s view that the recent selloff has created attractive long-term entry points.
Jim Cramer’s latest stock picks include Walmart, PepsiCo, Starbucks, TJX Companies, Johnson & Johnson and several biotechnology companies including Eli Lilly, Amgen, Vertex, Gilead Sciences and Regeneron.
Cramer believes Walmart’s recent share price decline has created an attractive buying opportunity. He expects lower fuel prices, resilient consumer demand and Walmart’s value-focused business model to support future growth.
Cramer currently favors defensive retail, consumer staples, healthcare, biotechnology and selected large-cap technology companies as market leadership rotates away from crowded semiconductor trades.
